Skip to main content
. 2020 Aug 24;38(30):3494–3505. doi: 10.1200/JCO.19.03107

FIG A3.

FIG A3.

Quality-adjusted progression-free survival (QA-PFS) for the intent-to-treat population determined by multiplying the investigator-assessed progression-free survival (PFS) function (A) by the EQ-5D-3L index score function (B) to obtain a QA-PFS function (C). (*) EQ-5D-3L data were collected on day 1 of each 28-day treatment cycle. PFS, progression-free survival; QA-PFS, quality-adjusted progression-free survival.